GBSI was launched in 2013, with the mission to promote the use of best practices and standards to improve the quality of life science research. GBSI was envisioned by ATCC CEO Dr. Ray Cypess who championed the idea that the biomedical community needed a thought leader dedicated to advancing best practices and standards. GBSI became operational in February 2013.
GBSI was initially funded by a generous grant from the BioNexus Foundation, a by ATCC. The BioNexus Foundation recognized the importance an organization like GBSI to improve the quality and reproducibility of biomedical research through standards and best practices. BioNexus continues to fund GBSI’s core activities. Today, GBSI also receives support to advance its mission from its Leadership Circle members and special grants from National Institutes of Health, Susan G. Komen, and several corporate sponsors. We thank these funders for their generous commitment.
GBSI’s work is laser-focused towards one end: to advance life science standards in support of credible, reproducible, and translatable outcomes in scientific research, thereby enhancing global health.
Since its inception in 2013, GBSI has worked to improve research quality and reproducibility by challenging the status quo and prevailing practices. The Five Year Review & the Road Ahead chronicles the significant impact GBSI has had on the research community since its inception and outlines its priorities for the future as it:
• Advances standards and best practices in life science research
• Strengthens and supports efforts of the life science stakeholder community towards that goal
• Improves biological research practices through education and training